Immanuel University Hospital Rüdersdorf, Brandenburg Medical School; Department of Neurology and Pain Therapy
Rüdersdorf bei Berlin, Germany
Jens Schmidt, MD, FEAN, FAAN, is chair of the Department of Neurology and pain treatment, Immanuel University Hospital Rüdersdorf, Brandenburg Medical School, Rüdersdorf/Berlin, Germany. He is Academic chair of the Neurology program of the Medical school and co-head of the Neuromuscular Center Brandenburg. He is chair of the national Myositis Network (MYOSITIS NETZ) in Germany and president of the International Myositis Society (iMyoS). His research interest encompasses a wide range of experimental Neuroimmunology as well as clinical and translational Neurology. His main focus is muscle inflammation – myositis. Prof. Schmidt has co-authored numerous high ranking research articles in these fields. He was trained in Würzburg, Southampton, Guildford, and London and has worked at the National Institutes of Health in Bethesda, USA. Prof. Schmidt is member of all relevant national and international professional societies in the field of Neuroimmunology and Neuromuscular disorders. He is Associate Editor at Journal of Cachexia, Sarcopenia and Skeletal Muscle, Frontiers Neurology, and BMC Neurology. He serves on international advisory boards and steering committees in the field of myositis. He has won several national and international prizes for his research in Neuroimmunology and Neuromuscular Disorders.
Mimics of Myositis: What’s Hiding in Plain Sight?
Saturday, October 25, 2025
9:20 AM – 9:55 AM Central Time
Disclosure(s): Abcuro: Advisor or Review Panel Member (Ongoing); Argenx: Advisor or Review Panel Member (Terminated, January 7, 2024); Biotest: Advisor or Review Panel Member (Terminated, January 16, 2023), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, January 16, 2023); CSL Behring: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Johnson & Johnson: Advisor or Review Panel Member (Ongoing); Kezar: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing); LFB: Advisor or Review Panel Member (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Lupin: Advisor or Review Panel Member (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Momenta: Advisor or Review Panel Member (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Octapharma: Advisor or Review Panel Member (Ongoing), Officer or Board Member (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); UCB: Advisor or Review Panel Member (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
